FDA and NRC pave way for domestic supply of medical isotope in diagnostic imaging
The U.S. Food and Drug Administration and the Nuclear Regulatory Commission (NRC) took steps to ensure a stable and secure supply of a critical radioactive imaging product used to detect potentially life-threatening diseases. The FDA approved the RadioGenix System, a unique system for producing Technetium-99m (Tc-99m), the most widely used radioisotope in medical imaging. The NRC is issuing guidance and will license the RadioGenix System to enable the Tc-99m it produces to be used for its medical purpose. More details at fda.gov
Amazon, Berkshire Hathaway, JPMorgan to form health care company
Amazon, Berkshire Hathaway and JPMorgan Chase & Co. will create an independent company "free from profit-making incentives and constraints" to address health care for their U.S. employees, the organizations announced. Details on businesswire.com.
COCIR releases position paper on Medical Device Regulation
COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry, has developed a document which provides a strategic and in-depth overview of the impact of Medical Device Regulation (MDR) on industry sectors. It addresses the general framework, pre- and post-market obligations for manufacturers as well as the relevant actors in the implementation process. This document will be updated on regular basis and can be viewed on the COCIR website.
Blindness gene therapy becomes most expensive medicine in U.S.
With a sticker price of $850,000, a gene therapy for blindness will be the most expensive medicine sold in the United States. The treatment called Luxturna is manufactured by Spark Therapeutics and helps treat Leber congenital aumaurosis, an inherited condition that leads to blindness. More details at Medical Daily.
What to expect in the healthcare industry in 2018
The digitalization keeps revolutinizing the sector, so how will it change the industry in 2018? A new trends report identified the top concerns and desires on the minds of industry leaders, while a Business Week author focuses on health tech trends worth watching in the coming year. Find out more: Trends report and tech developments.